Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.

Na-Na Sun,Chang Liu,Xiao-Lin Ge,Jie Wang
DOI: https://doi.org/10.5152/dir.2018.17369
2018-01-01
Diagnostic and Interventional Radiology
Abstract:PURPOSE We aimed to evaluate the treatment response of patients with esophageal cancer after concurrent chemoradiation therapy (CRT) using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). METHODS This retrospective study included 59 patients with histologically confirmed esophageal squamous cell carcinoma. The patients underwent DCE-MRI before and 4 weeks after CRT. Patients with complete response were defined as the CR group; partial response, stable disease, and progressive disease patients were defined as the non-CR group. DCE-MRI parameters (K-trans, V-e, and K-ep) were measured and compared between pre- and post-CRT in the CR and non-CR groups, respectively. Pre-CRT and post-CRT parameters were used to calculate the absolute change and the ratio of change. DCE-MRI parameters were compared between the CR and non-CR groups. Receiver operating characteristic (ROC) curves were used to verify diagnostic performance. RESULTS Patients with higher T-stage esophageal cancer might present with poorer response. After CRT, the K-trans and K-ep values significantly decreased in the CR group, whereas only K-ep value decreased in the non-CR group. The post-K-trans and post-K-ep values were observed to be significantly lower in the CR group than in the non-CR group. The absolute change and ratio of change of both K-trans and K-ep were higher in the CR group than in the non-CR group. Based on ROC analysis, the ratio of change in K-trans was the best parameter to assess treatment response (AUC=0.840). CONCLUSION DCE-MRI parameters are valuable in predicting and assessing concurrent CRT response for advanced esophageal cancer.
What problem does this paper attempt to address?